Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer

European Journal of Cancer

Volumn 36, Issue SUPPL. 4, 2000, Pages 73-

  Depypere, H T ^a   Bracke, M E ^a   Boterberg, T ^a   Mareel, M M ^a   Nuytinck, M ^b   Vennekens, K ^a   Serreyn, R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Laboratory M Nuytinck   (Belgium)

Author keywords

Breast cancer; Flavonoids; Tamoxifen; Tumour suppression

Indexed keywords

TAMOXIFEN; TANGERETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; FEMALE; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0033736684     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(00)00234-3     Document Type: Article

References (1)

1. Inhibition of Tamoxifen's therapeutic benefit by tangeretin in mammary cancer